Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review ; volume:18 ; number:1 ; day:6 ; month:12 ; year:2018 ; pages:1-5 ; date:12.2018
BMC ophthalmology ; 18, Heft 1 (6.12.2018), 1-5, 12.2018
- Creator
-
Ahn, Seong Joon
Joung, Jooyoung
Lee, Sang Hyup
Lee, Byung Ro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-018-0985-x
- URN
-
urn:nbn:de:101:1-2019012522384904728594
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ahn, Seong Joon
- Joung, Jooyoung
- Lee, Sang Hyup
- Lee, Byung Ro
- SpringerLink (Online service)
Other Objects (12)
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
Combined Intravitreal Dexamethasone Implant and Cataract Surgery in Patients with Diabetic Retinopathy: Effect on Retinal Morphology and Function
Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features
Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants
Demographic and clinical characteristics associated with screening practices for hydroxychloroquine retinopathy
Clock-hour topography and extent of outer retinal damage in hydroxychloroquine retinopathy
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
Combined Intravitreal Dexamethasone Implant and Cataract Surgery in Patients with Diabetic Retinopathy: Effect on Retinal Morphology and Function
Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features
Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants
Demographic and clinical characteristics associated with screening practices for hydroxychloroquine retinopathy
Clock-hour topography and extent of outer retinal damage in hydroxychloroquine retinopathy
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
Combined Intravitreal Dexamethasone Implant and Cataract Surgery in Patients with Diabetic Retinopathy: Effect on Retinal Morphology and Function
Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features
Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants
Demographic and clinical characteristics associated with screening practices for hydroxychloroquine retinopathy
Clock-hour topography and extent of outer retinal damage in hydroxychloroquine retinopathy
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis